AbbVie Inc.
Biopharmaceutical company based in North Chicago, Illinois, developing oncology and hematology therapeutics
Key metrics · each point sourced
Stated objectives
Develop and commercialize 35+ investigational medicines in multiple clinical trials across hematologic cancers
sourcePursue additional international regulatory approvals for the R/R FL indication
sourceEvaluate epcoritamab as monotherapy and in combination across lines of therapy in a range of hematologic malignancies through four ongoing Phase 3 trials
sourceAchieve adjusted diluted EPS for 2025
sourceAchieve high single-digit compound annual revenue growth rate for ex-Humira platform
sourceAchieve combined sales of immunology duo
sourceRaised full-year earnings guidance
sourceHigh single-digit CAGR through 2029
sourceDrive long-term growth through early-stage pipeline development
sourceReturn to robust revenue growth following Humira LOE
source